Division of Molecular Medicine and Gene Therapy
31 – 40 of 575
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
AKT1 induces Nanog promoter in a SUMOylation-dependent manner in different pluripotent contexts
(
- Contribution to journal › Article
-
Mark
Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity
(
- Contribution to journal › Article
-
Mark
Orchestrating an immune response to cancer with cellular reprogramming
2023) In Genes and Immunity(
- Contribution to journal › Article
-
Mark
Perspectives of current understanding and therapeutics of Diamond-Blackan anemia
2023) In Leukemia(
- Contribution to journal › Scientific review
-
Mark
Reprogramming Stars #10 : Modeling Cancer with Cellular Reprogramming-An Interview with Dr. Dung-Fang Lee
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The stem cell-supporting small molecule UM171 triggers Cul3-KBTBD4-mediated degradation of ELM2 domain-harboring proteins
(
- Contribution to journal › Article
-
Mark
MAC-1 marks a quiescent and functionally superior HSC subset during regeneration
(
- Contribution to journal › Article
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
(
- Contribution to journal › Article
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
(
- Contribution to journal › Article
-
Mark
Evaluation of genetic demultiplexing of single-cell sequencing data from model species
(
- Contribution to journal › Article